Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
Join A&M Managing Director, Debra Richman, as she talks with Marcus Osborne, SVP, Health & Wellness at Walmart to discuss healthcare strategy, the growth...
In Part II of our podcast, the discussion continues and dives into the impact of COVID-19 on patient volume, specifically as it relates to...
In this podcast, Health System leaders from across the country share their firsthand experience with the dynamic shifts in patient volume throughout the pandemic...
